Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2022-02-09 Regulatory Filings
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 92% confidence The document is a press release dated February 9, 2022, announcing that IMPLANET has commenced the first surgeries in the United States using its JAZZ™ PF product. It details the product's benefits, regulatory clearance (FDA 510(k)), market potential, and includes quotes from a surgeon and the CEO. This type of announcement, focusing on a specific operational or commercial milestone (like a product launch or first use in a major market), is characteristic of an Earnings Release (ER) if it were periodic, or more generally, a significant corporate announcement. Since it is not a full financial report (10-K, IR), a transcript (CT), or a specific regulatory filing like DIRS or DIV, it best fits the 'Earnings Release' category as it communicates key business performance/progress updates, even if it's not tied to a specific quarterly reporting date. However, given the content is a commercial/operational update rather than strictly financial results highlights, and it's not a formal regulatory filing like an 8-K (which isn't an option), the closest fit among the provided options that covers significant company news is ER, or potentially RNS if it were deemed a general regulatory announcement. Given the focus on commercial progress and market entry, ER is a strong candidate for a non-periodic, significant operational update that often accompanies or precedes formal earnings reports. Since it is a standalone announcement of a commercial event, ER (Earnings Release - initial announcement of periodical financial results/key highlights) is the most appropriate classification for a significant corporate update of this nature, although it is not strictly an earnings report.
2022-02-09 French
Inside Information / Other news releases
Regulatory Filings Classification · 90% confidence The document is a press release dated February 9, 2022, announcing the first surgeries in the United States using the JAZZ™ PF implant. It details the product's features, market potential, regulatory clearances (FDA 510(k)), and includes quotes from a surgeon and the CEO regarding the launch and market positioning. This content is characteristic of an announcement regarding a new product launch or significant business development, rather than a formal periodic financial report (like 10-K or IR) or a transcript. Since it is a specific business/product announcement and not a general regulatory filing (RNS), the most appropriate category is not explicitly listed among the core financial reports. However, given the context of announcing a major business milestone (product launch/market entry) with financial context, it most closely aligns with a general business update. Since there is no specific 'Product Launch' or 'Business Update' code, and it is not a standard financial filing, it falls best under the general 'Regulatory Filings' (RNS) as a catch-all for significant, non-standard announcements, or potentially 'Capital/Financing Update' (CAP) if the focus was on the market size/revenue potential, but the primary focus is the operational milestone. Given the options, and that it is a formal announcement of a significant operational event, RNS is the safest fallback, although it is a very specific type of announcement. Re-evaluating the definitions, this is a press release detailing a business event, not a formal regulatory filing like a change in management (MANG) or a dividend (DIV). It is not an Earnings Release (ER) as it doesn't report period results. It is not a Management Discussion (MDA). Therefore, RNS (Regulatory Filings - general regulatory announcements and fallback category) is the most suitable classification for this type of press release that doesn't fit the specific financial report codes.
2022-02-09 English
Inside Information / Other news releases
Report Publication Announcement Classification · 98% confidence The document is titled "IMPLANET announces its 2022 financial calendar" and explicitly lists the dates for future financial information releases, including Full-Year Results, Quarterly Revenue, and the Annual General Meeting. This document is not the actual financial report (like 10-K or IR) but an announcement about *when* those reports will be published. According to Rule 2, a short document announcing the publication of reports falls under Report Publication Announcement (RPA). The document length (2724 chars) supports this being an announcement rather than a full report.
2022-01-24 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is titled "IMPLANET annonce son agenda financier 2022" (IMPLANET announces its 2022 financial calendar). It explicitly lists future dates for key financial events such as annual results, quarterly sales, and the Annual General Meeting (AGM). Since the document's primary purpose is to announce *when* future reports and meetings will occur, rather than being the report itself (like an ER, IR, or 10-K) or the meeting materials (like AGM-R), it fits best under the category for announcing the publication of reports. Given the short length (2799 chars) and the nature of announcing future report releases, the most appropriate classification is Report Publication Announcement (RPA).
2022-01-24 French
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document is titled "IMPLANET annonce un chiffre d'affaires 2021 en hausse de 58% en normes IFRS" and contains detailed quarterly and annual revenue figures for the fiscal year 2021, comparing them to 2020. It explicitly discusses financial performance, strategic repositioning (acquisitions/cessions), and cash position as of December 31, 2021. This content structure—announcing period results with key figures and commentary—is characteristic of an Earnings Release (ER). Although it contains detailed tables, it is presented as a press release announcing the results, not the comprehensive statutory report (10-K) or a dedicated management discussion (MDA). Since it is the initial announcement of periodical financial results, ER is the most appropriate classification. FY 2021
2022-01-18 French
Inside Information / Information on annual revenues
Earnings Release Classification · 100% confidence The document is dated January 18, 2022, and explicitly announces the company's '2021 fourth-quarter revenue, annul revenue and cash position at December 31, 2021.' It contains detailed revenue tables broken down by quarter and full-year figures for 2021 compared to 2020, along with management commentary on performance and outlook. This content structure—reporting on a specific fiscal period (Q4 and Full Year 2021) with key financial metrics—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it covers the full year's performance alongside the final quarter, it leans towards an Earnings Release announcing the period's results, rather than a comprehensive annual report (10-K) or a detailed management discussion (MDA). Given the focus on revenue highlights and the announcement date shortly after year-end, 'ER' (Earnings Release) is the most appropriate classification, although it contains more detail than a typical press release, it is not the comprehensive statutory report. FY 2021
2022-01-18 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.